Model
Edge
TenX Keane Acquisition
TENK
Filing Type
8-K
Filing Date
12/9/2025
Updated
12/10/25, 3:29 PM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Unregistered Sales of Equity Securities, Other Events
EX-4.1
FORM OF COMMON WARRANT
EX-4.2
FORM OF PRE-FUNDED WARRANT
EX-4.3
FORM OF PLACEMENT AGENT WARRANT
EX-5.1
OPINION OF WYRICK ROBBINS YATES & PONTON LLP
EX-10.1
FORM OF REGISTERED DIRECT SECURITIES PURCHASE AGREEMENT, DATED AS OF DECEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE PURCHASER SIGNATORY THERETO
EX-10.2
FORM OF PIPE SECURITIES PURCHASE AGREEMENT, DATED AS OF DECEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE PURCHASER SIGNATORY THERETO
EX-10.3
FORM OF REGISTRATION RIGHTS AGREEMENT, DATED AS OF DECEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE PURCHASER SIGNATORY THERETO
EX-10.4
FORM OF WARRANT AMENDMENT AGREEMENT, DATED AS OF DECEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE INVESTOR SIGNATORY THERETO
EX-10.5
AMENDMENT TO PROMISSORY NOTE, DATED DECEMBER 10, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND CITIUS PHARMACEUTICALS, INC
EX-99.1
Material Contracts, Unregistered Sales of Equity Securities, Other Events
EX-99.1
Material Contracts, Unregistered Sales of Equity Securities, Other Events